Table 4.
Assessment of variables needed for the calculation of the disability adjusted life years (DALYs) in 39 studies analysing the health burden of infections caused by carbapenem-resistant Acinetobacter baumannii
| Available variable | Data missing | |
|---|---|---|
| Mortality (%) | ||
| N = 39 | ||
| Overall | 21 (54) | Long-term attributable mortality Gender-stratified mortality |
| Attributable | 10 (26) | |
| In hospital | 12 (31) | |
| No definition | 8 (20) | |
| 21–30-day mortality | 21 (54) | |
| Mortality stratified by age | 3 (8) | |
| Health states and their complications (%) | ||
| N = 39 | ||
| Health state | NA | Definition of most relevant non-fatal health outcomes |
| Duration of health states | ||
|
Acute complications Available in 35 out of 39 studies |
Prevalence and/or incidence of health states and associated mortality and complications Duration of health states |
|
| Need for intensive care unit | 9 (26) | |
| Hemodynamic instability | 10 (28) | |
| Renal impairment | 8 (23) | |
| Neurological impairment | 1 (3) | |
|
Health state duration (%) Available in 30 out of 39 studies | ||
| Clinical symptoms duration | NA | Agreement on duration of clinical symptoms Definition of appropriate follow-up An alternative to length of stay as indicator for disease duration could be the length of antibiotic therapy |
| Length of stay before infection | 19 (63) | |
| Length of stay after infection | 11 (37) | |
| Total length of stay | 12 (40) | |
| 1–3 months follow-up | 1 (3) | |
NA, not available.